These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3497279)

  • 21. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries.
    Förstermann U; Mügge A; Alheid U; Haverich A; Frölich JC
    Circ Res; 1988 Feb; 62(2):185-90. PubMed ID: 2448055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of nitrovasodilators, atrial natriuretic peptide and endothelium-derived nitric oxide.
    Murohara T; Kugiyama K; Yasue H
    J Vasc Res; 1996; 33(1):78-85. PubMed ID: 8603131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in basal endothelium-derived relaxing factor activity in different artery types.
    Collins P; Chappell SP; Griffith TM; Lewis MJ; Henderson AH
    J Cardiovasc Pharmacol; 1986; 8(6):1158-62. PubMed ID: 2434741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The acetylcholine paradox: a constrictor of human small coronary arteries even in the presence of endothelium.
    Angus JA; Cocks TM; McPherson GA; Broughton A
    Clin Exp Pharmacol Physiol; 1991 Jan; 18(1):33-6. PubMed ID: 2032388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relevance of endothelium-derived hyperpolarizing factor in the effects of hypertension on rat coronary relaxations.
    Vázquez-Pérez S; Navarro-Cid J; de las Heras N; Cediel E; Sanz-Rosa D; Ruilope LM; Cachofeiro V; Lahera V
    J Hypertens; 2001 Mar; 19(3 Pt 2):539-45. PubMed ID: 11327627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the endothelium and cyclic GMP in renal vasodilator responses to cryptolepine in rats.
    Oyekan AO
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):602-11. PubMed ID: 7516010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation by endothelium of the vascular effects of angiotensin II.
    Yilmaz G; Aksulu HE; Demirel E; Ercan ZS; Zengil H; Türker RK
    Agents Actions; 1987 Jun; 21(1-2):184-90. PubMed ID: 3307340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the endothelium in modulation of the acetylcholine vasoconstrictor response in porcine coronary microvessels.
    Myers PR; Banitt PF; Guerra R; Harrison DG
    Cardiovasc Res; 1991 Feb; 25(2):129-37. PubMed ID: 1742764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelium-derived relaxing factor: presence in pulmonary and systemic arteries of the newborn guinea pig.
    Davidson D; Eldemerdash A
    Pediatr Res; 1990 Feb; 27(2):128-32. PubMed ID: 2107513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity.
    Mügge A; Elwell JH; Peterson TE; Harrison DG
    Am J Physiol; 1991 Feb; 260(2 Pt 1):C219-25. PubMed ID: 1847583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of action of human calcitonin gene-related peptide in rabbit heart and in human mammary arteries.
    Raddino R; Pelà G; Manca C; Barbagallo M; D'Aloia A; Passeri M; Visioli O
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):463-70. PubMed ID: 9156355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelium-derived relaxing factor and the effects of acetylcholine and histamine on resistance blood vessels.
    Bhardwaj R; Moore PK
    Br J Pharmacol; 1988 Nov; 95(3):835-43. PubMed ID: 3264734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of acetylcholine-induced coronary resistance vessel dilation by hemoglobin.
    Stewart DJ; Münzel T; Bassenge E
    Eur J Pharmacol; 1987 Apr; 136(2):239-42. PubMed ID: 3595722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for endothelium-derived relaxing factor/nitric oxide in equine digital arteries.
    Cogswell AM; Johnson PJ; Adams HR
    Am J Vet Res; 1995 Dec; 56(12):1637-41. PubMed ID: 8599526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chylomicron-remnant-like particles inhibit receptor-mediated endothelium-dependent vasorelaxation in pig coronary arteries.
    Goulter AB; Avella MA; Elliott J; Botham KM
    Clin Sci (Lond); 2002 Nov; 103(5):451-60. PubMed ID: 12401117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. H2O2 and endothelium-dependent cerebral arteriolar dilation. Implications for the identity of endothelium-derived relaxing factor generated by acetylcholine.
    Wei EP; Kontos HA
    Hypertension; 1990 Aug; 16(2):162-9. PubMed ID: 2379949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor.
    Gryglewski RJ; Palmer RM; Moncada S
    Nature; 1986 Apr 3-9; 320(6061):454-6. PubMed ID: 3007998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine mediates nitric-oxide-independent renal vasodilation by activation of A2A receptors.
    Rump LC; Jabbari-T J; von Kügelgen I; Oberhauser V
    J Hypertens; 1999 Dec; 17(12 Pt 2):1987-93. PubMed ID: 10703900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelium-derived relaxing and contracting factors.
    Furchgott RF; Vanhoutte PM
    FASEB J; 1989 Jul; 3(9):2007-18. PubMed ID: 2545495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of EDRF release from freshly harvested endothelial cells on the coronary circulation of the isolated working rabbit heart.
    Hartmann A; Saeed M; Metz M; Bing RJ
    Microcirc Endothelium Lymphatics; 1988 Feb; 4(1):21-44. PubMed ID: 3288857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.